A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Conditions
Epidermal Growth Factor · Epidermal Growth Factor Receptor · Epidermal Growth Factor Receptor Gene Mutation · Non Small Cell · Non Small Cell Lung · Non Small Cell Lung Cancer · Head and Neck · Head and Neck Cancer · Head and Neck Cancers · Head and Neck Squamous Cell Cancer · Head and Neck Squamous Cell Carcinoma · Head and Neck Squamous Cell Carcinoma HNSCC · NSCLC (Non-small Cell Lung Cancer) · HNSCC · EGFR
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
START Los Angeles, Los Angeles, California, United States
Contact: Study coordinator (EpiBiologics Clinical Trials) · hopeteam@startreseach.com · 650-955-7486Astera Cancer Care, East Brunswick, New Jersey, United States
Contact: Study coordinator (EpiBiologics Clinical Trials) · hopeteam@startresearch.com · 650-955-7486START New York Long Island, Lake Success, New York, United States
Contact: Study coordinator (EpiBiologics Clinical Trials) · hopeteam@startresearch.com · 650-955-7486Sarah Cannon and HCA Research Institute, Nashville, Tennessee, United States
Contact: Study coordinator (EpiBiologics Clinical Trials) · clinicaltrials@epibiologics.com · 650-955-7486MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (EpiBiologics Clinical Trials) · clinicaltrials@epibiologics.com · 650-955-7486South Texas Accelerated Research Therapeutics (START), San Antonio, Texas, United States
Contact: Study coordinator (EpiBiologics Clinical Trials) · hopeteam@startreseach.com · 650-955-7486